• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

    57.64 +0.01 (+0.02%)
    Streaming Delayed Price Updated: 3:15 PM EST, Jan 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,486,677
    Open 57.64
    Bid (Size) 57.64 (8,500)
    Ask (Size) 57.65 (3,500)
    Prev. Close 57.63
    Today's Range 57.62 - 57.69
    52wk Range 5.666 - 57.70
    Shares Outstanding 34,358,152
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The Great Consolidation: US M&A Values Double as AI and Bio-Pharma Spark $2 Trillion Surge
    As of January 26, 2026, the American corporate landscape is undergoing its most radical transformation in a generation. Following a two-year period of high-interest-rate hibernation, the United States... 
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    Halper Sadeh LLC Encourages NATH, RAPT, FONR Shareholders to Contact the Firm to Discuss Their Rights
    Shareholders should contact the firm as there may be limited time to enforce your rights 
    From Halper Sadeh LLC
    Via GlobeNewswire

    Performance

    YTD
    +81.0%
    +81.0%
    1 Month
    +62.7%
    +62.7%
    3 Month
    +91.5%
    +91.5%
    6 Month
    +354.9%
    +354.9%
    1 Year
    +521.1%
    +521.1%

    More News

    Read More
    News headline image
    RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Why Rapt Therapeutics Stock Soared Today ↗
    Via The Motley Fool
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    Tuesday's session: top gainers and losers ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
    Via MarketMinute
    Topics Intellectual Property
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    RAPT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of RAPT Therapeutics, Inc. is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Why Did RAPT Stock Surge 63% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    Via The Motley Fool
    News headline image
    Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    RAPT Therapeutics Announces Proposed Public Offering of Common Stock
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Rapt Therapeutics, Outperforming 98% Of All Stocks, Skyrockets After Topping Roche ↗
    Via Investor's Business Daily
    News headline image
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga

    Frequently Asked Questions

    Is RAPT Therapeutics, Inc. - Common Stock publicly traded?
    Yes, RAPT Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does RAPT Therapeutics, Inc. - Common Stock trade on?
    RAPT Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for RAPT Therapeutics, Inc. - Common Stock?
    The ticker symbol for RAPT Therapeutics, Inc. - Common Stock is RAPT on the Nasdaq Stock Market
    What is the current price of RAPT Therapeutics, Inc. - Common Stock?
    The current price of RAPT Therapeutics, Inc. - Common Stock is 57.64
    When was RAPT Therapeutics, Inc. - Common Stock last traded?
    The last trade of RAPT Therapeutics, Inc. - Common Stock was at 01/26/26 03:15 PM ET
    What is the market capitalization of RAPT Therapeutics, Inc. - Common Stock?
    The market capitalization of RAPT Therapeutics, Inc. - Common Stock is 1.98B
    How many shares of RAPT Therapeutics, Inc. - Common Stock are outstanding?
    RAPT Therapeutics, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.